The physician programs referenced on this website provide access to compounded medications that are NOT FDA-approved. The FDA has not reviewed these compounded medications for safety, effectiveness, or quality. An alternative — prescription of FDA-approved branded medications such as Ozempic®, Wegovy®, Mounjaro®, or Zepbound® — may be available through the prescribing physician at different pricing.
Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective owners and are not affiliated with TrimRx or this editorial website.
All articles, assessment tools, and content on this website are for informational and educational purposes only. Nothing constitutes medical advice, diagnosis, or treatment recommendation.
GLP-1 receptor agonists may cause side effects including nausea, vomiting, diarrhea, constipation, and decreased appetite. Serious potential risks include pancreatitis, gallbladder disease, kidney injury from dehydration, and hypoglycemia. A personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) is a contraindication. These medications are not appropriate for patients with Type 1 diabetes or diabetic ketoacidosis. Discuss your complete medical history with your physician before starting treatment.
Before beginning any prescription weight loss program, consult your own physician or a licensed healthcare provider. This is especially important if you have pre-existing medical conditions, take prescription medications, or have concerns about drug interactions.
Clinical statistics cited (e.g., average weight loss of 15–17%) reflect controlled trial averages. Individual results vary significantly based on starting weight, adherence, activity level, and individual biology. Results are not guaranteed.
This website contains affiliate links (Campaign ID: O6114). If you enroll through our links, we may receive compensation. This is an advertising platform. The editorial format presents information accessibly but this is not a news publication.
TRYHARDGG SOLUTIONS LIMITED · 20 Dimotiki Agora, Larnaca 2060, Cyprus
[email protected]